LIS
ABBV icon

Legacy Investment Solutions’s AbbVie ABBV Stock Holding History

Legacy Investment Solutions’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$10.8K Buy
+58
New +$10.8K 0.01% 305
2024
Q4 		$1.52K Sell
8
-69
-90% -$12.7K ﹤0.01% 539
2024
Q3 		$13.1K Buy
+77
New +$14.4K 0.01% 268

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Legacy Investment Solutions's ABBV Position: Q2 2025 in Review

Legacy Investment Solutions opened a new position in AbbVie (ABBV) in Q2 2025: 58 shares worth $10.8K. The stake represents 0.01% of the portfolio and ranks #305 among its holdings. This is a return to the name: Legacy Investment Solutions previously reported a position in ABBV as recently as Q4 2024.

Legacy Investment Solutions first reported a position in ABBV in Q3 2024 and has held it in 3 quarters since. The position peaked at $13.1K in Q3 2024. 3,780 funds tracked by Wall St. Rank hold ABBV as of Q2 2025.

  • Legacy Investment Solutions held 58 shares of AbbVie worth $10.8K as of Q2 2025.
  • AbbVie was a new Legacy Investment Solutions position in Q2 2025.
  • AbbVie made up 0.01% of Legacy Investment Solutions's portfolio in Q2 2025, its #305 holding.
  • Legacy Investment Solutions first reported a position in AbbVie in Q3 2024 and has held it in 3 quarters since.
  • Legacy Investment Solutions's AbbVie position peaked at $13.1K in Q3 2024.
  • 3,780 funds tracked by Wall St. Rank held AbbVie as of Q2 2025.

Based on Legacy Investment Solutions's 13F filing for Q2 2025, filed 6 Aug 2025.